Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Zavicefta sales and marketing update

Pfizer launched Zavicefta ceftazidime/avibactam in the U.K. and Germany to treat complicated infections caused

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE